UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
________________
FORM 8-K
|
|
|
CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|
|
|
Date of report (Date of earliest event reported): January 22, 2008 (January 23, 2008) |
|
|
CORE LABORATORIES N.V.
(Exact name of registrant as specified in its charter)
001-14273
(Commission File Number)
|
The Netherlands |
Not Applicable |
|
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) |
|
|
|
|
Herengracht 424 |
|
|
1017 BZ Amsterdam |
|
|
The Netherlands |
Not Applicable |
|
(Address of principal executive offices) |
(Zip Code) |
|
|
|
Registrant's telephone number, including area code: (31-20) 420-3191
Check the appropriate below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
___ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
___ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
___ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b)) |
|
___ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4 (c)) |
Item 1.01 Entry into Material Definitive Agreement
On January 22, 2008, Core Laboratories N.V. and certain of its subsidiaries, entered into the Fourth Amended and Restated Credit Agreement, which we refer to as the "Amended Credit Agreement," with various financial institutions which are or may become parties to the Amended Credit Agreement (collectively, the "Lenders"), Bank of America, N.A. as administrative agent for the Lenders and as a letter of credit issuing bank.
The Amended Credit Agreement has been amended at the request of the administrative agent to include certain provisions customary for credit facilities of this type. There were no material amendments or modifications to the interest rate or related margins, lending commitments, financial covenants and related ratios, or the term of the agreement.
The foregoing description does not purport to be a complete description of the amendments or the Amended Credit Agreement and is qualified in its entirety by reference to the Amended Credit Agreement, which is filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference.
Item 9.01 Financial Statements, Pro Forma Financial Information and Exhibits
|
(c) |
Exhibits |
10.1 Fourth Amended and Restated Credit Agreement
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
Core Laboratories N.V. |
||||
|
|
|
|
|
|
|
|
|
Dated: January 23, 2008 |
|
By |
|
/s/ Richard L. Bergmark |
|
|
|
|
|
|
|
Richard L. Bergmark |
|
|
|
|
|
|
|
Chief Financial Officer |
|
|
CORE LABORATORIES N.V.
EXHIBIT INDEX TO FORM 8-K
|
|
|
|
|
EXHIBIT NO. |
|
ITEM |
|
|
|
|
|
10.1 |
|
Fourth Amended and Restated Credit Agreement |